Adaptive Biotechnologies (ADPT) Treasury Shares (2018 - 2019)

Adaptive Biotechnologies has reported Treasury Shares for 9 years, with the latest figure at $9.0 million in Q1 2026.

• Quarterly Treasury Shares fell 23.36% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 million (down 23.36% YoY) and the FY2025 annual result came in at $11.2 million, up 10.52% from the prior year.
• Treasury Shares slipped to $9.0 million in Q1 2026 per ADPT's latest filing, from $11.2 million in the prior quarter.
• Over five years, Treasury Shares peaked at $12.0 million in Q1 2024 and troughed at $5.4 million in Q3 2025.
• A 5-year average of $9.2 million and a median of $10.2 million in 2024 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares soared 742.56% in 2022, then sank 48.85% in 2025.
• Over 5 years, Treasury Shares stood at $6.0 million in 2022, then soared by 61.65% to $9.7 million in 2023, then increased by 5.23% to $10.2 million in 2024, then gained by 10.52% to $11.2 million in 2025, then slipped by 19.58% to $9.0 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $9.0 million, $11.2 million, and $5.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.